iNOS is frequently upregulated in the tumor microenvironment, driven by inflammatory cytokines such as IL-6 and TNF-α, as well as hypoxic conditions that activate transcription factors like hypoxia-inducible factor-1 alpha (HIF-1α). This evidence concerns the gene NOS2 and neoplasm.